Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound” or the "Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation ...

Fourth quarter revenue growth estimated at 105% to 110% year-over-year –– Company to start reporting in accordance with U.S. GAAP and filing ...

Sonalleve ® has also been approved by the China National Medical Products Administration for the non-invasive treatment of uterine fibroids and has FDA approval under a Humanitarian Device Exemption ...

Unsafe Abortion, Secondary Infertility, Infertility Factors, Tubal Infertility, Sub-Saharan Setting Unsafe abortion (USA) is defined as the termination of a non-desired pregnancy, performed by an ...

We apologize, but this video has failed to load. Try refreshing your browser, or tap here to see other videos from our team. The TULSA procedure, performed using Profound’s TULSA-PRO ® system, has the ...